Fumiko Suzuki
Overview
Explore the profile of Fumiko Suzuki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
372
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ozeki Y, Yokoyama A, Nishiyama A, Yoshida Y, Ohara Y, Mashima T, et al.
Sci Rep
. 2024 Apr;
14(1):9141.
PMID: 38644371
Tuberculosis remains a large health threat, despite the availability of the tuberculosis vaccine, BCG. As BCG efficacy gradually decreases from adolescence, BCG-Prime and antigen-booster may be an efficient strategy to...
2.
Suzuki F, Maeyama J, Kubota A, Nishimune A, Horiguchi S, Takii T, et al.
Vaccine
. 2023 Jan;
41(8):1447-1456.
PMID: 36702691
Mucosal vaccines offer several advantages over transdermal vaccines, including the ability to acquire systemic and mucosal immunities. Smoking is a huge public health threat and major risk factor for various...
3.
Maeyama J, Iho S, Suzuki F, Hayashi D, Yamamoto T, Yamazaki T, et al.
Tuberculosis (Edinb)
. 2021 Mar;
128:102067.
PMID: 33752142
Tuberculosis is a major threat to global health and its increased incidence in adolescents as well as onset in the elderly presents a serious problem. One strategy to control tuberculosis...
4.
Suzuki F, Okuno M, Tanaka T, Sanuki R
Genes Cells
. 2020 Sep;
25(11):741-752.
PMID: 32979863
MicroRNAs (miRNAs) are known to regulate gene expression and modulate cellular differentiation. MicroRNA-9/9* (miR-9/9*) and microRNA-124 (miR-124) are highly expressed in the central nervous system. In vivo function of miR-9/9*...
5.
Sanuki R, Tanaka T, Suzuki F, Ibaraki K, Takano T
Brain Behav Immun
. 2019 Apr;
80:427-438.
PMID: 30986429
Symptoms of many neurodegenerative diseases appear later in human life. However, young animal models for penetrating traumatic brain injury (pTBI) have been used to study neurodegenerative diseases and evaluate the...
6.
Miyaguchi J, Shiga K, Ogawa K, Suzuki F, Katagiri K, Saito D, et al.
Tohoku J Exp Med
. 2018 Aug;
245(4):269-275.
PMID: 30158369
Bacteria have been used for more than a century to treat solid tumors. Because solid tumors generate an anaerobic environment, we evaluated the anti-tumor effect of the obligate anaerobe strain...
7.
Suzuki F, Takeuchi M, Tachibana K, Isaka K, Inata Y, Kinouchi K
Am J Hosp Palliat Care
. 2017 Nov;
35(5):767-771.
PMID: 29179574
Background: Substantial variability exists among countries regarding the modes of death in pediatric intensive care units (PICUs). However, there is limited information on end-of-life care in Japanese PICUs. Thus, this...
8.
Itoh T, Hibi T, Suzuki F, Sugimoto I, Fujiwara A, Inaka K, et al.
PLoS One
. 2016 Dec;
11(12):e0167310.
PMID: 27907169
The Gram-positive bacterium Paenibacillus sp. str. FPU-7 effectively hydrolyzes chitin by using a number of chitinases. A unique chitinase with two catalytic domains, ChiW, is expressed on the cell surface...
9.
Shimada I, Kubota A, Katoh M, Suzuki F
Respir Investig
. 2016 Jan;
54(1):59-68.
PMID: 26718146
Background: Hyperoxia is a known cause of diffuse alveolar damage (DAD). We previously reported the transcript profiling of DAD induced by hyperoxia exposure in mouse lungs and showed that the...
10.
Iho S, Maeyama J, Suzuki F
Hum Vaccin Immunother
. 2015 Mar;
11(3):755-60.
PMID: 25751765
Bacterial DNA comprising palindromic sequences and containing unmethylated CpG is recognized by toll-like receptor 9 of plasmacytoid dendritic cells (pDCs) and induces the production of interferon-α and chemokines, leading to...